Propranolol Blocks Osteosarcoma Cell Cycle Progression, Inhibits Angiogenesis and Slows Xenograft Growth in Combination with Cisplatin-Based Chemotherapy

Researchers evaluated the antitumoral activity of propranolol using different in vitro and in vivo osteosarcoma preclinical models, alone or in addition to chemotherapy.